Displaying drugs 14901 - 14925 of 15549 in total
Omarigliptin
Omarigliptin has been used in trials studying the treatment of Type 2 Diabetes Mellitus and Chronic Renal Insufficiency.
Investigational
Matched Iupac: … (2R,3S,5R)-2-(2,5-difluorophenyl)-5-{2-methanesulfonyl-2H,4H,5H,6H-pyrrolo[3,4-c]pyrazol-5-yl}oxan-3- …
Matched Description: … Omarigliptin has been used in trials studying the treatment of Type 2 Diabetes Mellitus and Chronic Renal …
Matched Description: … Omarigliptin has been used in trials studying the treatment of Type 2 Diabetes Mellitus and Chronic Renal …
MK-0777
MK-0777 has been used in trials studying the treatment of Schizophrenia, Anxiety Disorder, and Generalized Anxiety Disorder.
Investigational
Matched Iupac: … 5-({[7-tert-butyl-3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]oxy}methyl)-1-ethyl-1H-1,2,4 …
Matched Description: … MK-0777 has been used in trials studying the treatment of Schizophrenia, Anxiety Disorder, and Generalized …
Matched Description: … MK-0777 has been used in trials studying the treatment of Schizophrenia, Anxiety Disorder, and Generalized …
Samalizumab
Samalizumab has been used in trials studying the treatment of Multiple Myeloma and B-cell Chronic Lymphocytic Leukemia.
Investigational
Matched Description: … Samalizumab has been used in trials studying the treatment of Multiple Myeloma and B-cell Chronic Lymphocytic …
Dihydrexidine
Dihydrexidine has been used in trials studying the treatment of SPD, Cocaine-Related Disorders, and Schizotypal Personality Disorder.
Investigational
Matched Description: … Dihydrexidine has been used in trials studying the treatment of SPD, Cocaine-Related Disorders, and Schizotypal …
Matched Categories: … Heterocyclic Compounds, 3-Ring …
Matched Categories: … Heterocyclic Compounds, 3-Ring …
Penclomedine
Penclomedine has been used in trials studying the treatment of Lymphoma and Unspecified Adult Solid Tumor, Protocol Specific.
Investigational
Matched Description: … Penclomedine has been used in trials studying the treatment of Lymphoma and Unspecified Adult Solid Tumor …
Icosabutate
Icosabutate is under investigation in clinical trial NCT02373176 ([14C] Icosabutate -A Phase I Absorption, Metabolism and Excretion Study).
Investigational
Matched Iupac: … 2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaen-1-yloxy]butanoic acid …
Matched Description: … Icosabutate is under investigation in clinical trial NCT02373176 ([14C] Icosabutate -A Phase I Absorption …
Matched Description: … Icosabutate is under investigation in clinical trial NCT02373176 ([14C] Icosabutate -A Phase I Absorption …
Racotumomab
Racotumomab has been used in trials studying the treatment of Glioma, Wilm's Tumor, Neuroblastoma, Retinoblastoma, and Ewing's Sarcoma.
Investigational
Matched Description: … Racotumomab has been used in trials studying the treatment of Glioma, Wilm's Tumor, Neuroblastoma, Retinoblastoma …
MORAb-066
MORAb-066 is a humanized antibody directed against tissue factor (TF). It is being investigated in pancreatic cancer.
Investigational
Matched Description: … It is being investigated in pancreatic cancer. ... MORAb-066 is a humanized antibody directed against tissue factor (TF). …
Ioforminol
Ioforminol has been used in trials studying the diagnostic of Cardio Renal Safety in High-risk Elderly Subjects Undergoing a Coronary CATH With or Without PCI.
Investigational
Matched Iupac: … 5-{N-[3-(N-{3,5-bis[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl}formamido)-2-hydroxypropyl]formamido …
Matched Description: … Subjects Undergoing a Coronary CATH With or Without PCI. ... Ioforminol has been used in trials studying the diagnostic of Cardio Renal Safety in High-risk Elderly …
Matched Description: … Subjects Undergoing a Coronary CATH With or Without PCI. ... Ioforminol has been used in trials studying the diagnostic of Cardio Renal Safety in High-risk Elderly …
BMS-986012
BMS-986012 is a human antifucosyl-GM1 antibody. It is under investigation in clinical trial NCT02815592 (Trial of BMS-986012 in Combination With Platinum and Etoposide).
Investigational
Matched Description: … BMS-986012 is a human antifucosyl-GM1 antibody. ... It is under investigation in clinical trial NCT02815592 (Trial of BMS-986012 in Combination With Platinum …
Davalintide
Davalintide is under investigation in clinical trial NCT00785408 (Study to Examine Safety, Tolerability and Effect on Body Weight of Subcutaneous AC2307 in Obese or Overweight Subjects).
Investigational
Matched Description: … and Effect on Body Weight of Subcutaneous AC2307 in Obese or Overweight Subjects). ... Davalintide is under investigation in clinical trial NCT00785408 (Study to Examine Safety, Tolerability …
Sisunatovir
Sisunatovir is under investigation in clinical trial NCT04267822 (Study of RV521 in the Treatment of Adult Subjects Who Have Undergone HCT With an URTI With RSV).
Investigational
Matched Iupac: … [cyclopropane-1,3'-indol]-2'-one ... 1'-{[5-(aminomethyl)-1-(4,4,4-trifluorobutyl)-1H-1,3-benzodiazol-2-yl]methyl}-6'-fluoro-1',2'-dihydrospiro …
Matched Description: … Sisunatovir is under investigation in clinical trial NCT04267822 (Study of RV521 in the Treatment of …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Matched Description: … Sisunatovir is under investigation in clinical trial NCT04267822 (Study of RV521 in the Treatment of …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
TRC150094
TRC150094 is under investigation in clinical trial NCT03254446 (Safety and Efficacy Study of TRC150094 to Improve the CV Risk in Subjects With Diabetes, Dyslipidemia and Hypertension).
Investigational
Matched Iupac: … 3-{4-[(7-hydroxy-6-methyl-2,3-dihydro-1H-inden-4-yl)methyl]-3,5-dimethyl-1H-pyrazol-1-yl}propanoic acid …
Matched Description: … to Improve the CV Risk in Subjects With Diabetes, Dyslipidemia and Hypertension). ... TRC150094 is under investigation in clinical trial NCT03254446 (Safety and Efficacy Study of TRC150094 …
Matched Description: … to Improve the CV Risk in Subjects With Diabetes, Dyslipidemia and Hypertension). ... TRC150094 is under investigation in clinical trial NCT03254446 (Safety and Efficacy Study of TRC150094 …
Deferitrin
Deferitrin is under investigation in clinical trial NCT00069862 (Iron Balance Study of DFO and GT56-252 in Patients With Transfusional Iron Overload Secondary to Beta-thalassemia).
Investigational
Matched Iupac: … (4S)-2-(2,4-dihydroxyphenyl)-4-methyl-4,5-dihydro-1,3-thiazole-4-carboxylic acid …
Matched Description: … in Patients With Transfusional Iron Overload Secondary to Beta-thalassemia). ... Deferitrin is under investigation in clinical trial NCT00069862 (Iron Balance Study of DFO and GT56-252 …
Matched Description: … in Patients With Transfusional Iron Overload Secondary to Beta-thalassemia). ... Deferitrin is under investigation in clinical trial NCT00069862 (Iron Balance Study of DFO and GT56-252 …
Ispronicline
Ispronicline is under investigation in clinical trial NCT00109564 (A Safety and Efficacy Study of Ispronicline (TC-1734-112) in Subjects With Age Associated Memory Impairment (AAMI)).
Investigational
Matched Iupac: … methyl[(2S,4E)-5-[5-(propan-2-yloxy)pyridin-3-yl]pent-4-en-2-yl]amine …
Matched Description: … Ispronicline is under investigation in clinical trial NCT00109564 (A Safety and Efficacy Study of Ispronicline ... (TC-1734-112) in Subjects With Age Associated Memory Impairment (AAMI)). …
Matched Description: … Ispronicline is under investigation in clinical trial NCT00109564 (A Safety and Efficacy Study of Ispronicline ... (TC-1734-112) in Subjects With Age Associated Memory Impairment (AAMI)). …
Tropifexor
Tropifexor is under investigation in clinical trial NCT02516605 (A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of Tropifexor (LJN452) in PBC Patients).
Investigational
Matched Iupac: … 2-[(1R,3R,5S)-3-({5-cyclopropyl-3-[2-(trifluoromethoxy)phenyl]-1,2-oxazol-4-yl}methoxy)-8-azabicyclo[ …
Matched Description: … Tropifexor is under investigation in clinical trial NCT02516605 (A Multi-part, Double Blind Study to ... Assess Safety, Tolerability and Efficacy of Tropifexor (LJN452) in PBC Patients). …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Matched Description: … Tropifexor is under investigation in clinical trial NCT02516605 (A Multi-part, Double Blind Study to ... Assess Safety, Tolerability and Efficacy of Tropifexor (LJN452) in PBC Patients). …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
PAT-1251
PAT-1251 is under investigation in clinical trial NCT04054245 (PAT-1251 in Treating Patients With Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, or Post-essential Thrombocytosis Myelofibrosis).
Investigational
Matched Iupac: … (3R,4R)-1-(3-{[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxy}benzoyl)-4-fluoropyrrolidin-3-ol …
Matched Description: … PAT-1251 is under investigation in clinical trial NCT04054245 (PAT-1251 in Treating Patients With Primary …
Matched Description: … PAT-1251 is under investigation in clinical trial NCT04054245 (PAT-1251 in Treating Patients With Primary …
Tobemstomig
Tobemstomig is under investigation in clinical trial NCT05908786 (A Study Evaluating the Efficacy and Safety of Neoadjuvant Immunotherapy Combinations in Patients With Surgically Resectable Hepatocellular Carcinoma).
Investigational
Matched Description: … Tobemstomig is under investigation in clinical trial NCT05908786 (A Study Evaluating the Efficacy and ... Safety of Neoadjuvant Immunotherapy Combinations in Patients With Surgically Resectable Hepatocellular …
RO7284755
RO7284755 is an investigational cancer drug: it is a PD-1-targeted IL-2 variant antibody fusion protein. RO7284755 is under investigation in clinical trial NCT04303858 (A Study to Evaluate Safety and Anti-tumor Activity of RO7284755 Alone or in Combination With Atezolizumab in Participants With Advanced And/or Metastatic Solid Tumors).
Investigational
Matched Description: … RO7284755 is an investigational cancer drug: it is a PD-1-targeted IL-2 variant antibody fusion protein ... RO7284755 is under investigation in clinical trial NCT04303858 (A Study to Evaluate Safety and Anti-tumor ... Activity of RO7284755 Alone or in Combination With Atezolizumab in Participants With Advanced And/or …
SB-649868
SB-649868 is under investigation in clinical trial NCT01030939 (Study to Investigate Safety, Tolerability, Pharmacokinetics and Cardiac Function After Repeat Doses of SB-649868 in Healthy-volunteers).
Investigational
Matched Iupac: … N-{[(2S)-1-[5-(4-fluorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]piperidin-2-yl]methyl}-1-benzofuran-4 …
Matched Description: … , Pharmacokinetics and Cardiac Function After Repeat Doses of SB-649868 in Healthy-volunteers). ... SB-649868 is under investigation in clinical trial NCT01030939 (Study to Investigate Safety, Tolerability …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Matched Description: … , Pharmacokinetics and Cardiac Function After Repeat Doses of SB-649868 in Healthy-volunteers). ... SB-649868 is under investigation in clinical trial NCT01030939 (Study to Investigate Safety, Tolerability …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
MK-8666
MK-8666 is under investigation in clinical trial NCT01971554 (Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of MK-8666 in Participants With Type 2 Diabetes Mellitus (MK-8666-003)).
Investigational
Matched Iupac: … (2S,3S,4R)-8-{[4'-(3-methanesulfonylpropoxy)-2',6'-dimethyl-[1,1'-biphenyl]-3-yl]methoxy}-9-azatricyclo ... [4.4.0.0^{2,4}]deca-1(6),7,9-triene-3-carboxylic acid …
Matched Description: … and Pharmacokinetics of MK-8666 in Participants With Type 2 Diabetes Mellitus (MK-8666-003)). ... MK-8666 is under investigation in clinical trial NCT01971554 (Safety, Tolerability, Pharmacodynamics, …
Matched Description: … and Pharmacokinetics of MK-8666 in Participants With Type 2 Diabetes Mellitus (MK-8666-003)). ... MK-8666 is under investigation in clinical trial NCT01971554 (Safety, Tolerability, Pharmacodynamics, …
Tigatuzumab
Tigatuzumab is under investigation in clinical trial NCT00991796 (CS-1008 With Carboplatin/Paclitaxel in Chemotherapy naïve Subjects With Metastatic or Unresectable Non-small Cell Lung Cancer (NSCLC)).
Investigational
Matched Description: … Tigatuzumab is under investigation in clinical trial NCT00991796 (CS-1008 With Carboplatin/Paclitaxel ... in Chemotherapy naïve Subjects With Metastatic or Unresectable Non-small Cell Lung Cancer (NSCLC)). …
Nimacimab
Nimacimab is under investigation in clinical trial NCT03261739 (Safety Tolerability, and PK of RYI-018 After Repeat Dosing in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)).
Investigational
Matched Description: … After Repeat Dosing in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)). ... Nimacimab is under investigation in clinical trial NCT03261739 (Safety Tolerability, and PK of RYI-018 …
Methylsamidorphan
Methylsamidorphan is under investigation in clinical trial NCT01418092 (ALK37-007: Evaluation of Safety and Efficacy of ALKS 37 (RDC-1036) in Adults With Opioid-induced Constipation (OIC)).
Investigational
Matched Iupac: … cyclopropylmethyl)-3,10-dihydroxy-17-methyl-13-oxo-17-azatetracyclo[7.5.3.0^{1,10}.0^{2,7}]heptadeca-2( …
Matched Description: … and Efficacy of ALKS 37 (RDC-1036) in Adults With Opioid-induced Constipation (OIC)). ... Methylsamidorphan is under investigation in clinical trial NCT01418092 (ALK37-007: Evaluation of Safety …
Matched Description: … and Efficacy of ALKS 37 (RDC-1036) in Adults With Opioid-induced Constipation (OIC)). ... Methylsamidorphan is under investigation in clinical trial NCT01418092 (ALK37-007: Evaluation of Safety …
Iscalimab
Iscalimab is under investigation in clinical trial NCT03905525 (Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sjögren's Syndrome).
Investigational
Matched Description: … Doses of CFZ533 in Two Distinct Populations of Patients With Sjögren's Syndrome). ... Iscalimab is under investigation in clinical trial NCT03905525 (Study of Safety and Efficacy of Multiple …
Displaying drugs 14901 - 14925 of 15549 in total